
PRVA Stock Forecast & Price Target
PRVA Analyst Ratings
Bulls say
Privia Health Group Inc. has demonstrated robust growth in provider additions, achieving the bull case of onboarding 125 providers in the fourth quarter of 2025, which positions the company for continued scalability. Financial projections for fee-for-service practice collections per provider show an upward trend, with a sequential increase of approximately 9% in the third quarter of 2025, bolstered by strong performance in the Arizona market and improvements in operational efficiency. The company's strategic initiatives in reducing administrative burdens for physicians and expanding its value-based care portfolio contribute to enhanced profitability and sustained revenue growth prospects.
Bears say
Privia Health Group Inc is facing a grim outlook due to anticipated declines in Medicaid enrollment, with an expected reduction of 8%-10% in membership by year-end, which is attributed to re-determination activities following the public health emergency. This scenario is further compounded by projections of a sequential decline in EBITDA after a strong performance in Q3, indicating potential challenges in maintaining profitability. Additionally, the company's expectations of a 2% quarter-over-quarter decrease in same-store metrics—despite typical seasonality trends predicting an increase—underscore ongoing operational difficulties that may negatively impact its financial stability.
This aggregate rating is based on analysts' research of Privia Health Group and is not a guaranteed prediction by Public.com or investment advice.
PRVA Analyst Forecast & Price Prediction
Start investing in PRVA
Order type
Buy in
Order amount
Est. shares
0 shares